TBIQYR4361-Global Insulin Pen Needles Market Research Report 2019

                                          
Insulin Pen needles are used in conjunction with injection pens to deliver injectable medications into the body. An insulin pen needle consists of a hollow needle which is embedded in a plastic hub and attaches to injection pens. Pen needles come in a variety of needle lengths and diameters and are used by both health professionals and patients for injection of a variety of medications. They are commonly used by people with diabetes who often require multiple daily insulin injections. 
The global average price of Insulin Pen Needles is in the decreasing trend, from 121.7 USD/K Unit in 2012 to 118.0 USD/K Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of Insulin Pen Needles includes Standard Insulin Pen Needles and Safety Insulin Pen Needles, and the proportion of Standard Insulin Pen Needles in 2016 is about 95%, and the proportion is in decreasing trend from 2012 to 2016.

Insulin Pen Needles is widely used for Home and Medical Institutions. The most proportion of Insulin Pen Needles is for home use, and the proportion in 2016 is about 92%. 

North America is the largest supplier of Insulin Pen Needles, with a production market share nearly 43.5% in 2016. Europe is the second largest supplier of Insulin Pen Needles Media, enjoying production market share nearly 38.7% in 2016.

Europe is the largest consumption place, with a consumption market share nearly 41% in 2016. Following Europe, North America is the second largest consumption place with the consumption market share of 30%. 

Market competition is not intense. BD, Novo Nordisk, Artsana, B. Braun, Terumo, Ypsomed, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. 


The global Insulin Pen Needles market is valued at 1530 million US$ in 2018 is expected to reach 2220 million US$ by the end of 2025, growing at a CAGR of 4.8% during 2019-2025.
This report focuses on Insulin Pen Needles volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin Pen Needles market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    BD
    Novo Nordisk
    Artsana
    B. Braun
    Terumo
    Ypsomed
    Owen Mumford
    HTL-Strefa
    Beipu
    Kangdelai
    Ulticare
    Allison Medical
    Dongbao

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Standard Insulin Pen Needles
    Safety Insulin Pen Needles

Segment by Application
    Home Use
    Medical Institutions
    Others